Animal models of steatosis

Seminars in Liver Disease

Volumn 21, Issue 1, 2001, Pages 89-104

  Koteish, A ^a   Diehl, A M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Energy; Insulin; Leptin; Mitochondria; Peroxisomes

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ALCOHOL; AROMATASE; CCAAT ENHANCER BINDING PROTEIN; CHOLINE; DIPHTHERIA TOXIN; ESTROGEN; ETOMOXIR; FATTY ACID; GLUCOCORTICOID; INSULIN; LEPTIN; METHIONINE; SOMATOMEDIN B; STAT5B PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ANIMAL MODEL; ENZYME DEFICIENCY; FATTY ACID OXIDATION; GENE DELETION; GENE OVEREXPRESSION; GENETIC MODEL; GLUCOSE INTAKE; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID DIET; LIPODYSTROPHY; LIPOGENESIS; MITOCHONDRION; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; NUTRITIONAL DEFICIENCY; OBESITY; PRIORITY JOURNAL; PROTEIN RESTRICTION; RAT STRAIN; REVIEW; STEATOSIS;

EID: 0035078599     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12932     Document Type: Review

References (107)

1. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines
2. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: The PPAR alpha-null mouse as a model of fatty acid oxidation disorders
3. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting
4. Hepatocellular and hepatic peroxisomal Alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene
5. Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: Generation of a mouse model of pseudoneonatal adrenoleukodystrophy
6. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
7. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice
8. Steatohepatitis, spontaneous peroxisome proliferation and tumors in mice lacking peroxisomal and fatty acyl-CoA oxidase
9. Increased levels of nuclear SREP-1c associated with fatty livers in two mouse models of diabetes mellitus
10. Stat 5B, activated by insulin in a Jak- independent fashion, plays a role in glucokinase gene transcription
11. Glucose down regulates the expression of the PPAR alpha gene in the pancreatic beta cell
12. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY 14,643
13. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGFI) in normal rats
14. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism
15. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a
16. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREP-1c in adipose tissue: Model for congenital generalized lipodystrophy
17. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
18. Life without white fat: A transgenic mouse
19. Biological role of the CCAAT enhancer-binding protein family of transcription factors
20. Impaired energy homeostasis in C/EBP alpha knockout mice
21. C/EBP alpha: A critical regulator of genes governing integrative metabolic processes
22. Targeted expression ora toxin gene to adipose tissue: Transgenic mice resistant to obesity
23. Troglitazone action is independent of adipose tissue
24. Functional roles of STAT family proteins: Lessons from knockout mice
25. Stat 5B, activated by insulin in a Jak- independent fashion, plays a role in glucokinase gene transcription
26. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
27. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes
28. The OB protein (leptin) pathway - A link between adipose tissue mass and central neural networks
29. Effects of the obese gene product on body weight regulation in ob/ob mice
30. Obesity increases sensitivity to endotoxin liver injury: Implications for pathogenesis of steatohepatitis
31. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion
32. Leptin deficiency enhances sensitivity to endotoxin-induced lethality
33. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity, in TNF-alpha- and obesity-induced insulin resistance
34. Metformin reverses nonalcoholic fatty liver disease in obese leptin-deficient mice
35. The uncoupling proteins, a review
36. Uncoupling: New approaches to an old problem of bioenergetics
37. Altered expression of hepatic Cyp2E1 and Cyp4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats
38. Identification and expression cloning of a leptin receptor, OB-R
39. Defective STAT signaling by the leptin receptor in diabetic mice
40. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
41. Induction of UCP2 mRNA by troglitazone in pancreatic islets of Zucker diabetic fatty rats
42. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation
43. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice
44. + channels in pancreatic beta cells
45. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
46. Reversing adipocyte differentiation: Implications for treatment of obesity
47. Rosiglitazone (BRL49653), a PPAR gamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
48. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
49. Bacterial lipopolysaccharide induces uncoupling protein- 2 in hepatocytes via a tumor necrosis alpha-dependent mechanism
50. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors
51. Abnormal splicing of the leptin receptor in diabetic mice
52. Leptin receptor missense mutation in the fatty Zucker rat
53. Effects of leptin and cholecystokinin in rats with a null mutation of the leptin tin receptor Lepr-fak
54. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets
55. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
56. Antiobesity and antidiabetic actions of a new potent disaccharidase inhibitor in genetically obese-diabetic mice, KKAy
57. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
58. Liver fibrosis in overweight patients
59. Individual severity of dietary obesity in unselected Wistar rats: Relationship with hyperphagia
60. Morphological changes of organs after sucrose or fructose feeding
61. Biochemical changes in liver and blood during liver fattening in rats
62. Fatty liver induced in Zucker "fatty" (ff) rats by a semisynthetic diet rich in sucrose
63. Hypolipidemic action of phytic acid (IP6): Prevention of fatty liver
64. Production and prevention of fatty liver in rats fed clofibrate and orotic acid diets containing sucrose
65. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity
66. Biochemical, pathological, and genetic aspects of a spontaneous mouse hepatoma
67. Genetic obesity and neoplasia
68. Anti-obesity action of oolong tea
69. Species specificity of arginine deficiency-induced hepatic steatosis
70. Infection of hypercholesterolemic mice with Coxsackie virus B
71. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice
72. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
73. Lipoatrophy produced in mice and rabbits by a fraction prepared from the urine from patients with congenital generalized lipodystrophy
74. Transgenic mice lacking white fat: Models for understanding human lipoatrophic diabetes
75. Biochemical factors in alcoholic liver disease
76. + availability in F344 rats
77. Quantitative relationship between amount of dietary fat and severity of alcoholic fatty liver
78. Regression of alcoholic fatty liver in the rat by medium-chain triglycerides
79. Dietary arachidonic acid protects mice against the fatty liver induced by a high fat diet and by ethanol
80. The feeding of alcohol in liquid diets: Two decades of applications and 1982 update
81. Ethanol-induced liver fibrosis in rats fed high fat diets
82. Cytokines and alcoholic liver disease
83. Altered T-lymphocyte responsiveness to polyclonal cell activators is responsible for liver cell necrosis in alcohol-fed rats
84. Concanavalin A-induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice
85. Experimental liver cirrhosis induced by alcohol and iron
86. Antibiotics prevent liver injury in rats following long-term exposure to ethanol
87. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease
88. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
89. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice
90. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation
91. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells
92. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition
93. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon
94. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice
95. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis
96. Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2 strain of mouse with similarities to Reye's syndrome
97. Animal model of systemic carnitine deficiency: Analysis in C3H-2 strain of mouse associated with juvenile visceral steatosis
98. Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency
99. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
100. Cyp2E1 and Cyp4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
101. Cirrhosis with steatohepatitis after adjuvant tamoxifen
102. Tamoxifen-induced steatohepatitis
103. Tamoxifen-associated steatohepatitis: Report of three cases
104. Tamoxifen-induced steatohepatitis
105. Effects of female sex hormones on mitochondria: Possible role in acute fatty liver of pregnancy
106. Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta oxidation
107. Lipids up-regulate uncoupling protein-2 expression in rat hepatocytes